SDSS Catalog of Stars in the Draco Dwarf Spheroidal Galaxy

The Sloan Digital Sky Survey (SDSS) has scanned the entire region containing the Draco dwarf spheroidal galaxy to 23rd magnitude in g*. We present a catalog of stars found in a 453 square arcminute, elliptical region centered on the Draco dwarf spheroidal galaxy. Objects in the catalog are matched with five previously published catalogs. The catalog contains SDSS photometry for 5634 individual objects, and also the photometry from matches to any of the other catalogs. A comparison of the photometry between catalogs allows us to identify 142 candidate variable objects. One hundred and twelve of the suspected variables have colors consistent with RR Lyrae variables.Comment: To appear in ApJS 14 pages, 6 figure

The Ghost of Sagittarius and Lumps in the Halo of the Milky Way

We identify new structures in the halo of the Milky Way Galaxy from positions, colors and magnitudes of five million stars detected in the Sloan Digital Sky Survey. Most of these stars are within 1.26 degrees of the celestial equator. We present color-magnitude diagrams (CMDs) for stars in two previously discovered, tidally disrupted structures. The CMDs and turnoff colors are consistent with those of the Sagittarius dwarf galaxy, as had been predicted. In one direction, we are even able to detect a clump of red stars, similar to that of the Sagittarius dwarf, from stars spread across 110 square degrees of sky. Focusing on stars with the colors of F turnoff objects, we identify at least five additional overdensities of stars. Four of these may be pieces of the same halo structure, which would cover a region of the sky at least 40 degrees in diameter, at a distance of 11 kpc from the Sun (18 kpc from the center of the Galaxy). The turnoff is significantly bluer than that of thick disk stars, and closer to the Galactic plane than a power-law spheroid. We suggest two models to explain this new structure. One possibility is that this new structure could be a new dwarf satellite of the Milky Way, hidden in the Galactic plane, and in the process of being tidally disrupted. The other possibility is that it could be part of a disk-like distribution of stars which is metal-poor, with a scale height of approximately 2 kpc and a scale length of approximately 10 kpc. The fifth overdensity, which is 20 kpc away, is some distance from the Sagittarius dwarf streamer orbit and is not associated with any known structure in the Galactic plane. It is likely that there are many smaller streams of stars in the Galactic halo.Comment: ApJ, in press; 26 figures including several in colo

Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases.

The Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guideline for the Management of Glomerular Diseases is an update to the KDIGO 2012 guideline. The aim is to assist clinicians caring for individuals with glomerulonephritis (GN), both adults and children. The scope includes various glomerular diseases, including IgA nephropathy and IgA vasculitis, membranous nephropathy, nephrotic syndrome, minimal change disease (MCD), focal segmental glomerulosclerosis (FSGS), infection-related GN, antineutrophil cytoplasmic antibody (ANCA) vasculitis, lupus nephritis, and anti-glomerular basement membrane antibody GN. In addition, this guideline will be the first to address the subtype of complement-mediated diseases. Each chapter follows the same format providing guidance related to diagnosis, prognosis, treatment, and special situations. The goal of the guideline is to generate a useful resource for clinicians and patients by providing actionable recommendations based on evidence syntheses, with useful infographics incorporating views from experts in the field. Another aim is to propose research recommendations for areas where there are gaps in knowledge. The guideline targets a broad global audience of clinicians treating GN while being mindful of implications for policy and cost. Development of this guideline update followed an explicit process whereby treatment approaches and guideline recommendations are based on systematic reviews of relevant studies, and appraisal of the quality of the evidence and the strength of recommendations followed the "Grading of Recommendations Assessment, Development and Evaluation" (GRADE) approach. Limitations of the evidence are discussed, with areas of future research also presented